ConductScience.org, home

Paper33737643

A dose-escalating toxicology study of the candidate biologic ELP-VEGF.

Waller JP and 4 others. Sci Rep, 2021. Cited by 14 papers, by iCite.

Cite this record

ConductScience Library. A dose-escalating toxicology study of the candidate biologic ELP-VEGF. Papers, record 33737643. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33737643

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
A dose-escalating toxicology study of the candidate biologic ELP-VEGF.
PubMed
Journal
Sci Rep
PubMed
Year
2021
PubMed
Publication types
Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
1.07
iCite
Revised in PubMed
2023-01-29
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Waller JPJamarius P
2Burke SPStephen P
3Engel JJason
4Chade ARAlejandro R
5Bidwell GL 3rdGene L

Source PubMed

Download CSV of authors

Topics26

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Biological ProductsMajor topic
Breast NeoplasmsMajor topic
ElastinMajor topic
Neovascularization, PathologicMajor topic
Recombinant Fusion ProteinsMajor topic
Renal Insufficiency, ChronicMajor topic
Vascular Endothelial Growth Factor AMajor topic
Animals
Blood Pressure
Body Weight
Capillary Permeability
Disease Models, Animal
Female
Gene Expression
Glomerular Filtration Rate
Heterografts
Humans
Hypotension
Mice
Molecular Mimicry
Neovascularization, Physiologic
Rats
Rats, Sprague-Dawley
Swine
Toxicity Tests, Chronic
X-Ray Microtomography

Source PubMed

Download CSV of topics

Grants6

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
R01 HL121527NHLBI NIH HHSUnited StatesR01HL121527PubMed and NIHNIH RePORTER
P20 GM104357NIGMS NIH HHSUnited StatesP20GM104357PubMed and NIHNIH RePORTER
R01 HL095638NHLBI NIH HHSUnited StatesR01HL095638PubMed and NIHNIH RePORTER
F31 HL151180NHLBI NIH HHSUnited StatesF31HL151180PubMed and NIHNIH RePORTER
R41 DK109737NIDDK NIH HHSUnited StatesR41DK109737PubMed and NIHNIH RePORTER
P01 HL051971NHLBI NIH HHSUnited StatesP01HL051971PubMed and NIHNIH RePORTER

Download CSV of grants

References39

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
129477157US Renal Data System 2017 Annual Data Report: Epidemiology of Kidney Disease in the United States.Am J Kidney Dis2018https://conductscience.org/library/papers/29477157PubMed
225704344Epidemiology of hypertension in CKD.Adv Chronic Kidney Dis2015https://conductscience.org/library/papers/25704344PubMed
319244479Chronic hypoxia attenuates VEGF signaling and angiogenic responses by downregulation of KDR in human endothelial cells.Am J Physiol Cell Physiol2009https://conductscience.org/library/papers/19244479PubMed
419934087Role of renal microcirculation in experimental renovascular disease.Nephrol Dial Transplant2010https://conductscience.org/library/papers/19934087PubMed
520587789Renal microvascular disease determines the responses to revascularization in experimental renovascular disease.Circ Cardiovasc Interv2010https://conductscience.org/library/papers/20587789PubMed
631542966Targeted VEGF (Vascular Endothelial Growth Factor) Therapy Induces Long-Term Renal Recovery in Chronic Kidney Disease via Macrophage Polarization.Hypertension2019https://conductscience.org/library/papers/31542966PubMed
722357917Reversal of renal dysfunction by targeted administration of VEGF into the stenotic kidney: a novel potential therapeutic approach.Am J Physiol Renal Physiol2012https://conductscience.org/library/papers/22357917PubMed
825653833Growth factor purification and delivery systems (PADS) for therapeutic angiogenesis.Vasc Cell2015https://conductscience.org/library/papers/25653833PubMed
912152001A target-mediated model to describe the pharmacokinetics and hemodynamic effects of recombinant human vascular endothelial growth factor in humans.Clin Pharmacol Ther2002https://conductscience.org/library/papers/12152001PubMed
101464614Dual regulation of vascular endothelial growth factor bioavailability by genetic and proteolytic mechanisms.J Biol Chem1992https://conductscience.org/library/papers/1464614PubMed
11963023Synthetic, cross-linked polypentapeptide fo tropoelastin: an anisotropic, fibrillar elastomer.Biochemistry1976https://conductscience.org/library/papers/963023PubMed
1226578439Elastin-like polypeptides: Therapeutic applications for an emerging class of nanomedicines.J Control Release2016https://conductscience.org/library/papers/26578439PubMed
1331786977Biopolymer-Delivered, Maternally Sequestered NF-κB (Nuclear Factor-κB) Inhibitory Peptide for Treatment of Preeclampsia.Hypertension2020https://conductscience.org/library/papers/31786977PubMed
1425823650Reducing the Visibility of the Vector/DNA Nanocomplexes to the Immune System by Elastin-Like Peptides.Pharm Res2015https://conductscience.org/library/papers/25823650PubMed
1527784692A kidney-selective biopolymer for targeted drug delivery.Am J Physiol Renal Physiol2017https://conductscience.org/library/papers/27784692PubMed
1626541349Renal Therapeutic Angiogenesis Using a Bioengineered Polymer-Stabilized Vascular Endothelial Growth Factor Construct.J Am Soc Nephrol2016https://conductscience.org/library/papers/26541349PubMed
1729273331Systemic biopolymer-delivered vascular endothelial growth factor promotes therapeutic angiogenesis in experimental renovascular disease.Kidney Int2018https://conductscience.org/library/papers/29273331PubMed
185043412Tumor dormancy in vivo by prevention of neovascularization.J Exp Med1972https://conductscience.org/library/papers/5043412PubMed
191940805Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels.J Exp Med1991https://conductscience.org/library/papers/1940805PubMed
201309029Vascular permeability factor, fibrin, and the pathogenesis of tumor stroma formation.Ann N Y Acad Sci1992https://conductscience.org/library/papers/1309029PubMed

See all 39 referencesDownload CSV of references

Cited by10

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
42776284Angiogenesis-promoting properties of phosphorylcholine mimetic nanoparticles.Angiogenesis2026https://conductscience.org/library/papers/42776284PubMed
42514909Protein-Based Nanomaterials for Cancer Therapy: A Comparative and Translational Perspective.Pharmaceutics2026https://conductscience.org/library/papers/42514909PubMed
42165956Angiogenic Doping: Plausible Yet Difficult to Detect.Sports Med2026https://conductscience.org/library/papers/42165956PubMed
42094280Rational design and preclinical evaluation of elastin-like polypeptide micelle nanoparticles for drug delivery.Front Bioeng Biotechnol2026https://conductscience.org/library/papers/42094280PubMed
41837883Growth factor applications and clinical translation: advances and challenges.Ann Med2026https://conductscience.org/library/papers/41837883PubMed
41528341Optimizing delivery of an anti-cytomegalovirus inhibitory peptide using a cell-penetrating peptide.J Gen Virol2026https://conductscience.org/library/papers/41528341PubMed
40339045Value of Bioinformatics Models for Predicting Translational Control of Angiogenesis.Circ Res2025https://conductscience.org/library/papers/40339045PubMed
35652363Novel Drug Delivery Technologies and Targets for Renal Disease.Hypertension2022https://conductscience.org/library/papers/35652363PubMed
35215284Gelatin Methacrylate Hydrogel for Tissue Engineering Applications-A Review on Material Modifications.Pharmaceuticals (Basel)2022https://conductscience.org/library/papers/35215284PubMed
34486397Novel Protein Therapeutics Created Using the Elastin-Like Polypeptide Platform.Physiology (Bethesda)2021https://conductscience.org/library/papers/34486397PubMed

Download CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
KDR3791PubTator's text mininghttps://conductscience.org/library/genes/3791NCBI Gene
NR5A12516PubTator's text mininghttps://conductscience.org/library/genes/2516NCBI Gene
VEGFA7422PubTator's text mininghttps://conductscience.org/library/genes/7422NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/33737643

GET https://conductscience.org/api/papers/v1/33737643/references?page=2